Program Schedule (Download PDF version)

  Time Monday, April 25
 
  1000 Registration Opens
  1300-1500 Poster Set-up
  1600 Opening Plenary Session
Bill Barrable, Rick Hansen Institute; Graham Creasey, Praxis 2016 Chair; Hon. Carla Qualtrough, Federal Minister of Sport and Persons with Disabilities; Eric Marcotte, Canadian Institutes of Health Research; Rick Hansen, Rick Hansen Foundation; Jennifer French, Neurotech Network; Kim Anderson-Erisman, Miami Project to Cure Paralysis; Francesco Marincola, Sidra Medical & Research Center - Sponsored by BC Cancer Agency
  1745 Welcome Reception / Poster Session

  Time Tuesday, April 26
Valley 1 – Bench to Bedside		 Wednesday, April 27
Valley 2 – Bedside to Worldwide
 
  0730 Breakfast - Sponsored by Interface Health Society Breakfast - Sponsored by Interface Health Society
   
  0800
   
  0830 Opening Remarks Opening Remarks
   
  0900

SESSION 1: PRODUCT DEVELOPMENT AND DELIVERY – CHALLENGES AND SOLUTIONS IN DEVICE, DRUG AND CELLULAR THERAPIES - Sponsored by Asterias Biotherapeutics
Chair: Graham Creasey, Professor of Spinal Cord Injury Medicine, Stanford University

Lessons Learned Panel:
  1. P. Hunter Peckham, Donnell Institute Professor of Biomedical Engineering
  2. Andrew Blight, Chief Scientific Officer, Acorda Therapeutics
  3. Edward Wirth, Chief Medical Officer, Asterias Biotherapeutics 
  4. Megan Moynahan, Executive Director, Institute for Functional Restoration

Panel Interaction 		SESSION 3: BRINGING KNOWLEDGE INTO CLINICAL PRACTICES
Chair: Catherine Truchon, Senior Advisor, Trauma Team, Institut National d’Excellence en Santé et Services Sociaux

Perspective Panel: Using What We Know
  1. Anthony Burns, Physiatrist, UHN-Toronto Rehabilitation Institute
  2. Mark Bayley, Medical Director, Brain & Spinal Cord Rehab Program, UHN-Toronto Rehabilitation Institute
  3. Cathy Craven, Medical Lead, Brain & Spinal Cord Rehab Program, Toronto Rehabilitation Institute
    Associate Professor, Dept of Medicine, University of Toronto

Panel Interaction
Plenary Q and A
   
   
   
  1000
   
  1030 Refreshment Break
   
  1100 Working Group Discussion and Plenary Summary Working Group Discussion and Plenary Summary
   
   
   
  1200
Lunch - Sponsored by AOSpine Lunch & Sponsor Showcase
Lunch sponsored by Ontario Neurotrauma Foundation
   
   
   
  1300
  1315
SESSION 2: PRE-CLINICAL AND CLINICAL TRIALS OF REGENERATION AND REPAIR IN SCI
Chair: Naomi Kleitman, Senior Vice President for Grants & Research, Craig H. Neilsen Foundation

Case Study Experiences Panel:
  1. Lyn Jakeman, Program Director, National Institute of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)
  2. Brian Kwon, Canada Research Chair in Spinal Cord Injury, University of British Columbia
  3. Michele (Shelly) Towle, Assistant Director, SCI Program, DP Clinical

Panel Interaction
Plenary Q and A 		SESSION 4: FINANCIAL VIABILITY - UNCERTAIN MARKETS INVESTORS, INDUSTRY, IP AND INSURANCE -PRODUCT DEVELOPMENT AND REIMBURSEMENT
Chair: Lisa McKerracher, Founder and CEO, BioAxone BioSciences

Experience-in-Action Panel:
  1. Phil Tinmouth, Vice President & Head, Business Development & Alliance Management, Vertex Pharmaceuticals Inc
  2. Kathleen Marsman, Patent Agent, Borden Ladner Gervais LLP
  3. Dennis Choi, Professor and Chair, Department of Neurology, Stony Brook Medicine
  4. Ron Podraza, Co-Founder and CEO, Reimbursement Principles, Inc.

Panel Interaction
   
   
  1400
   
  1430 Working Sessions: Preclinical and Clinical Research Working Group Discussion and Plenary Summary
   
  1500 Refreshment Break
  1520 Working Group Discussion and Plenary Summary Plenary Discussion with Panel Members
   
   
  1600
  1610 Plenary Summary Closing Session: Research Into Action -
Perspectives on the Way Forward
   
  1700 Session Closing Conference Ends
  1730-1900 Networking Reception & Resource Centre